Tumor-LN-oC project 

April 25, 2022

The European Health and Digital Executive Agency (HaDEA) featured Tumor-LN-oC project in a special article for World Health Day for its contribution to an innovative and resilient health industry in Europe

Lung cancer is one of the biggest health challenges of our times. In many cases, tumours use lymphatic vessels to spread and colonise downstream lymph nodes (LNs). Tumor-LN-oC is finding a solution for a robust, automated tumour–lymph node-on-chip platform, which will connect surgically removed, human primary tumours and lymph node tissue from the same lung cancer patient.

The project thus uses advances in the fields of microfluidics, cellbiology, cancer biology, physics and computer programming to study the metastasis through the lymphatic system and the interaction of primary tumours with LNs, what will make it possible to offer personalised treatment to lungcancer patients based on the molecular characterisation of their own metastasising cells.

Asphalion is proud Regulatory partner throughout the project.

You can visit the project website for more information: 💻➡️ https://tumor-ln-oc.eu/

Additionally, you can also contact us for further information: info@asphalion.com 

Search News & Events

  • Filter by category

Share

Related news and events

RBDCOV | 14-months follow-up meeting

The second face-to-face RBDCOV meeting is taking place today at Palau Macaya in Barcelona! Our expert, Chris Mann, is attending the meeting in person. After

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting